KTOS, OXGN, SWKS, - CRWESelect.com Stock News! Kratos Defense & Security Solutions, OXiGENE, Skyworks Solutions (Video Included Inside)

FOR IMMEDIATE RELEASE
Las Vegas, Nevada, United States of America (Free-Press-Release.com) November 3, 2011 -- To view video, and read the full article visit URL http://crweselect.com/27149/stock-alerts/ktos-oxgn-swks-crweselectcom-stock-news-kratos-defense-security-solutions-oxigene-skyworks-solutions-video-included-inside/

Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS)

KTOS reported today third quarter 2011 revenues of $211.0 million, up from third quarter 2010 revenues of $119.9 million, and third quarter 2011 Adjusted EBITDA of $29.5 million, or 14.0% of revenues, up year-over-year from $11.7 million, or 9.8% of revenues, from the third quarter of 2010. Kratos' third quarter adjusted EBITDA margin of 14.0% reflects the continued successful integration of Kratos' strategic acquisitions and the related expected cost synergies, notably in the recently closed acquisition of Integral Systems. The third quarter adjusted EBITDA rate of 14.0% also reflects a favorable program and contract mix for the quarter, including in the Cyber Security, Electronic Warfare, Electronic Attack and Intelligence, Surveillance and Reconnaissance related business areas.

KTOS is a specialized National Security Technology business providing mission critical products, services and solutions for United States National Security priorities. KTOS core capabilities are sophisticated engineering, manufacturing and system integration offerings for National Security platforms and programs. KTOS areas of expertise include C5ISR, satellite communication systems, unmanned systems, cyber warfare, cyber security, information assurance, critical infrastructure security and weapons systems sustainment. KTOS, including the recent acquisition of Integral, has primarily an engineering and technical oriented work force of approximately 3,900, many of whom hold an active National Security clearance, including Secret, Top Secret and higher. The vast majority of KTOS work is performed on a military base, in a secure facility or at a critical infrastructure location. KTOS primary end customers are United States Federal Government agencies, including the Department of Defense, classified agencies, intelligence agencies and Homeland Security related agencies.

For more information about KTOS please visit http://www.kratosdefense.com/

****

OXiGENE, Inc. (NASDAQ:OXGN)

OXGN announced final results today from the FALCON trial, a stratified, randomized, controlled Phase 2 study of ZYBRESTAT(TM) (fosbretabulin tromethamine, or CA4P) in patients with advanced non-small cell lung cancer (NSCLC). The final analysis of the data showed that the combination regimen of ZYBRESTAT plus bevacizumab, carboplatin and paclitaxel (ZYBRESTAT arm) was observed to be well-tolerated with no significant cumulative toxicities or overlapping toxicities with bevacizumab when compared with the control arm of the study (standard chemotherapy plus bevacizumab). In addition, an analysis of patients with tumor burden greater than 10 cm suggested meaningful improvements in overall survival for patients receiving ZYBRESTAT in addition to bevacizumab and chemotherapy. For patients with this large tumor burden, median overall survival was 14.2 months, compared with 11.0 months for patients on the control arm of the study. For the overall patient population, no survival benefit was observed for patients receiving ZYBRESTAT.

OXGN is a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases. The Company's major focus is developing vascular disrupting agents that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment. OXGN is dedicated to leveraging its intellectual property and therapeutic development expertise to bring life-extending and life-enhancing medicines to patients.

For more information about OXGN please visit http://www.oxigene.com

****

Skyworks Solutions, Inc. (NASDAQ:SWKS)

SWKS reported today fourth fiscal quarter and year end 2011 results. Revenue for the quarter was $402.3 million versus guidance of $400 million, and was up 28 percent year-over-year and 13 percent sequentially. For fiscal year 2011, revenue was $1.419 billion versus $1.072 billion in fiscal 2010, a 32 percent increase.

SWKS is an innovator of high reliability analog and mixed signal semiconductors. Leveraging core technologies, SWKS offers diverse standard and custom linear products supporting automotive, broadband, cellular infrastructure, energy management, industrial, medical, military and mobile handset applications. The Company’s portfolio includes amplifiers, attenuators, circulators, detectors, diodes, directional couplers, front-end modules, hybrids, infrastructure RF subsystems, isolators, mixers/demodulators, optocouplers, optoisolators, phase shifters, PLLs/synthesizers/VCOs, power dividers/combiners, receivers, switches and technical ceramics. Headquartered in Woburn, Mass., SWKS is worldwide with engineering, manufacturing, sales and service facilities throughout Asia, Europe and North America.

For more information about SWKS please http://www.skyworksinc.com/

To read the full article visit URL http://crweselect.com/27149/stock-alerts/ktos-oxgn-swks-crweselectcom-stock-news-kratos-defense-security-solutions-oxigene-skyworks-solutions-video-included-inside/

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

KTOScrweselect1103
OXGNcrweselect1103
SWKScrweselect1103

Kratos Defense Security     KTOS     NASDAQ KTOS     NASDAQ OXGN     OXGN     OXiGENE     Skyworks Solutions     SWKS